Delivery Order SPE2DB22D1017-SPE2DB25FE7LP
Award Date
10/18/24
Potential Completion Date
11/8/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 3, 2024. There is no set-aside designation for this award. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of pharmaceutical products and medical...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a performance period through August 7, 2024. The contract is a Firm Fixed Price arrangement. There is no set-aside designation mentioned for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price Delivery Order. This contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, is the prime...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of November 25, 2024. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of June 5, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of August 1, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The $12,960.30 firm fixed price delivery order has an ultimate completion date of October 11, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary...
This federal contract award, valued at $13,846.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through May 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with an ultimate completion date of August 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through...